Peripheral Perfusion Index Trajectory to Predict 28-Day Mortality in Patients With Sepsis in the Intensive Care Unit
NCT07740304
Critical Illness, Disease Attributes
Edirne, Merkez, Turkey (Türkiye)
View Trial DetailsNCT Number: NCT02936232
The aim of this study is to construct multi-center sepsis registry that can be used for data warehousing and clinical research.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea
This registry prospectively enrolls adult patients with severe sepsis or septic shock in 21 tertiary hospital emergency departments.
Registered data can be used for quality control and clinical research to reduce sepsis-related mortality.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 28-day
According to hospital discharge record review and telephone follow-up.
Time frame: 90-day
According to hospital discharge record review and telephone follow-up.
Time frame: hospital discharge (non-survivors) or 90 days (survivors)
According to hospital record review
Time frame: hospital discharge (non-survivors) or 90 days (survivors)
According to hospital record review
Time frame: hospital discharge (non-survivors) or 90 days (survivors)
According to hospital record review
Time frame: hospital discharge (non-survivors) or 90 days (survivors)
According to hospital record review
Contact information is provided by the study sponsor or research team.
Kyung Su Kim, MD, PhD
CONTACT
Woon Wong Kwon, MD, PhD
CONTACT
Seoul National University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07740304
Critical Illness, Disease Attributes
Edirne, Merkez, Turkey (Türkiye)
View Trial DetailsNCT07215702
Acute Kidney Injury, Female Urogenital Diseases
Tucson, Arizona, United States
View Trial DetailsNCT07727265
Infections, Inflammation
Nanjing, Jiangsu, China
View Trial DetailsNCT07502794
Infections, Inflammation
Passo Fundo, Rio Grande do Sul, Brazil
View Trial Details